Table 3.
Adverse Events, Additional Surgeries, Shunt Revision, Hemorrhage, and Air Inclusion (Values are Given as Absolute Frequency or as Mean ± Standard Deviation).
| FH | GU | P | |
|---|---|---|---|
| Patients with AE/SAE (n) | 22 | 20 | .67 |
| AE (n) | 29 | 21 | .14 |
| SAE (n) | 19 | 17 | .66 |
| Additional surgeries (n) | 6 | 9 | .43 |
| Shunt revisions (n) | 4 | 9 | .15 |
| Ventricular catheter revisions (n) | 1 | 2 | .57 |
| Hemorrhage (n) | 5 | 6 | .77 |
| Hemorrhage volume (cm3) (range) | 0.55 ± 0.75 (0.003-1.86) | 0.71 ± 0.79 (0.075-1.88) | .71 |
| Air inclusion (n) | 51 | 50 | .74 |
AE – adverse events; SAE – severe adverse events.